Elucidating the precise pharmacological mechanism of action (MOA) of naturally happening compounds could be challenging. Even though Tarselli et al. (60) designed the 1st de novo artificial pathway to conolidine and showcased that this naturally developing compound properly suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers